Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Converge Coverage

  • 1
    News

    Cardiac biomarkers refine antihypertensive drug initiation decisions

    January 22, 2020

    PHILADELPHIA – Analysis showcases a better way to select patients for intensive BP lowering.

  • 1
    News

    Children with resistant UTIs unexpectedly may respond to discordant antibiotics

    January 17, 2020

    A low rate of care escalation and high rate of clinical improvement suggest this may be a reasonable approach until urine culture sensitivities return.

  • 1
    News

    SPRINT-type BP control provides up to 3 years of additional life

    January 14, 2020

    PHILADELPHIA – Survival advantage of intensive over standard blood pressure lowering is age dependent.

  • 1
    News

    Treatment of heart failure with preserved ejection fraction is a work in progress

    January 13, 2020

    Although the disorder has a lower mortality than heart failure with reduced ejection fraction, it places a significant burden on health care systems.

  • 1
    News

    PACT-HF: Transitional care derives no overall benefit

    January 9, 2020

    PHILADELPHIA – A trial of a postdischarge transitional care model found no improvement in outcomes overall, but showed that women responded more favorably than men.

  • 1
    News

    New hypertension performance measures boost 130/80 mm Hg target

    January 6, 2020

    PHILADELPHIA – Hypertension performance and quality measures from the AHA and ACC provide a guide for implementing the 2017 hypertension guideline.

  • 1
    News

    ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding

    December 16, 2019

    LOS ANGELES – Use of novel oral anticoagulants may be preferred over vitamin K antagonists in patients with diabetes and AFib.

  • 1
    News

    New ASH guideline: VTE prophylaxis after major surgery

    December 12, 2019

    ORLANDO – The chair of VTE guidelines panel presented highlights of the latest guidelines in a special session at the annual meeting of the American Society of Hematology.

  • 1
    News

    Cardiac arrhythmia heightens mortality risk during epilepsy hospitalizations

    December 11, 2019

    BALTIMORE – A secondary diagnosis of apnea is not independently associated with increased odds of death, however.

  • 1
    News

    Genetic test stratified AFib patients with low CHA2DS2-VASc scores

    December 9, 2019

    A 32-locus genetic test classified AFib patients with low CHA2DS2-VASc scores into high– and low–stroke-risk subgroups.

Previous1 … 41 42 43 44 45 … 105Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences